Form 4: Astera Labs Director Michael Hurlston Receives Significant RSU Grant

Astera Labs, Inc. Director Michael E. Hurlston was granted 2,351 restricted stock units (RSUs) on June 8, 2025, as part of the company's 2024 Stock Option and Incentive Plan.

Summary

• Michael E. Hurlston, a Director of Astera Labs, Inc. (ALAB), reported a change in beneficial ownership via a Form 4 filing.
• On June 8, 2025, Mr. Hurlston acquired 2,351 shares of Common Stock through an award of Restricted Stock Units (RSUs).
• These RSUs were granted under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan.
• The RSUs are set to vest in full upon the earlier of the first anniversary of the grant date (June 8, 2025) or the date of the next annual stockholder meeting of the Company following the grant date, subject to Mr. Hurlston's continuous service.
• Each RSU represents a contingent right to receive one share of Astera Labs' Common Stock.
• Following this transaction, Mr. Hurlston beneficially owns a total of 91,645 shares of Common Stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is a positive step for aligning management incentives with shareholder interests, though it is a routine compensation event and does not indicate extraordinary performance or issues.

Positives

• The grant of 2,351 Restricted Stock Units (RSUs) to Director Michael E. Hurlston aligns management's long-term interests with shareholder value creation.
• The vesting schedule, tied to continuous service, encourages the director's ongoing commitment to the company.

Future Outlook

NA

Industry Context

This Form 4 filing details a routine insider compensation event, specifically the grant of restricted stock units to a director. Such grants are a common practice across industries to incentivize and retain key personnel by aligning their financial interests with the long-term performance of the company.

Related Party Transactions

• The grant of Restricted Stock Units (RSUs) to Director Michael E. Hurlston constitutes a transaction with a related party, which is a standard form of director compensation under the company's existing 2024 Stock Option and Incentive Plan.

Stakeholder Impact

• Shareholders: The RSU grant is designed to align the director's financial interests with the long-term performance and value creation for shareholders.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Vesting of the 2,351 Restricted Stock Units (RSUs) will occur upon the earlier of June 8, 2026 (the first anniversary of the grant date) or the date of the next annual stockholder meeting, contingent on Michael E. Hurlston's continuous service relationship with Astera Labs, Inc.

Key Dates

Recommendation

Keywords

Astera Labs, ALAB, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Director Compensation, Beneficial Ownership, Stock Option Plan